← back to search

Thuy Vu

Amgen (United States) · US
Area of research
Neurology · Psychiatry and Mental health
Research interest
Research interests include Migraine, Medicine, Pharmacology, Pharmacokinetics, Calcitonin gene-related peptide, and Capsaicin.
h-index
citations
191
works
2
NIH funding
primary concept
email

Recent publications

Phase I, Randomized, Double‐blind, Placebo‐controlled, Single‐dose, and Multiple‐dose Studies of Erenumab in Healthy Subjects and Patients With Migraine
Clinical Pharmacology & Therapeutics 2017cited by 96position: middledoi
Pharmacokinetic-Pharmacodynamic Relationship of Erenumab (AMG 334) and Capsaicin-Induced Dermal Blood Flow in Healthy and Migraine Subjects
Pharmaceutical Research 2017cited by 95position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Anne Van Hecken · KU Leuven2 papers (2017–2017)Lisa Hamilton · University of Colorado Denver2 papers (2017–2017)Lucy Yan · Amgen (United States)2 papers (2017–2017)Jiyun S Chen · Amgen (United States)2 papers (2017–2017)Gabriel Vargas · Amgen (United States)2 papers (2017–2017)Jan de Hoon · KU Leuven2 papers (2017–2017)Edgar Bautista · Amgen (United States)1 papers (2017–2017)Corinne Vandermeulen · KU Leuven1 papers (2017–2017)Javier C. Waksman · Amgen (United States)1 papers (2017–2017)Brian P. Smith · Leidos (United States)1 papers (2017–2017)Peiming Ma · Amgen (United States)1 papers (2017–2017)Liviawati S. Wu · Amgen (United States)1 papers (2017–2017)